Perioperative magnesium supplementation to prevent atrial fibrillation after off-pump coronary artery surgery: a randomized controlled study

J Cardiothorac Vasc Anesth. 2005 Dec;19(6):723-8. doi: 10.1053/j.jvca.2005.02.015.

Abstract

Objective: Atrial fibrillation is a common complication after cardiac surgery. Magnesium is an effective and safe antiarrhythmic agent for arrhythmias that develop after cardiac surgery. The authors performed a study to evaluate the role of perioperative magnesium for prophylaxis of atrial fibrillation after off-pump coronary artery surgery.

Design: Randomized controlled study.

Setting: University teaching hospital.

Participants: One hundred sixty consecutive patients undergoing elective, isolated, off-pump coronary artery bypass grafting were prospectively randomized into 2 groups.

Interventions: Patients in the magnesium group (n = 80) received a 2.5-g (20 mEq) magnesium sulphate infusion intraoperatively over 30 minutes, and the placebo group (n = 80) received normal saline solution.

Measurements and main results: Postoperative atrial fibrillation occurred in 16 of 80 patients (20%) in the magnesium group and in 18 of 80 (22.5%) in the placebo group (p = 0.9).

Conclusion: The use of 2.5 g of intraoperative magnesium showed no effect in preventing atrial fibrillation after off-pump coronary artery bypass.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Analysis of Variance
  • Atrial Fibrillation / prevention & control*
  • Coronary Artery Bypass, Off-Pump*
  • Double-Blind Method
  • Female
  • Humans
  • Magnesium / therapeutic use*
  • Male
  • Middle Aged
  • Postoperative Complications / prevention & control*
  • Prospective Studies
  • Sample Size

Substances

  • Magnesium